Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Organocatalytic Atroposelective Formal C(sp2)-H Alk(en)ylation: Enantioselective Synthesis of Class 2 Atropisomeric Quinones.

Created on 24 Jun 2026

Authors

Subhajit Mondal, Santanu Mukherjee

Published in

Journal of the American Chemical Society. Jun 24, 2026. Epub Jun 24, 2026.

Abstract

The borderline rotational barrier of class 2 atropisomeric quinones makes their enantioselective synthesis challenging. Herein we report the first catalytic atroposelective formal C(sp2)-H methylation and alkenylation of atropisomerically labile 2-aryl (naphtho)quinones. Employing nitroalkanes as alk(en)ylating agents, these reactions are catalyzed by a bifunctional tertiary aminourea derivative and proceed via dynamic kinetic resolution (DKR). The resulting 2-aryl 3-alk(en)yl quinones exhibit rotational barriers characteristic of class 2 atropisomers and are isolated in good to excellent yields with generally exclusive (E)-selectivity and high enantioselectivity. The synthetic utility of 2-aryl 3-alk(en)yl quinones is showcased through several stereospecific downstream transformations. Mechanistic studies reveal that the byproduct nitrite acts as the terminal oxidant in the alkenylation pathway. To the best of our knowledge, this is the first time nitroalkanes have been shown to function as alkenylating agents, at least in an enantioselective transformation.

PMID:
42340360
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement